Probiotics in pediatric gastrointestinal disorders

被引:15
作者
Davidson, GP [1 ]
Butler, RN [1 ]
机构
[1] Womens & Childrens Hosp, Ctr Paediat & Adolescent Gastroenterol, Adelaide, SA 5006, Australia
关键词
D O I
10.1097/00008480-200010000-00010
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Probiotics have been defined most recently as living microorganisms which, upon ingestion in certain numbers, exact health benefits beyond inherent general nutrition. They have been a part of human nutrition for centuries, but in recent years they have been more closely studied for their potential to improve health and treat disease. This review of probiotics is not extensive, highlighting the most recent reviews and well controlled clinical studies in both animals and humans. The safety issues are also discussed as well as potential mechanisms of action. The importance of studying each probiotic bacterium individually in each condition where a health benefit is claimed is highlighted by Lactobacillus GG, the most widely studied probiotic which has proven benefit in reducing the severity and duration of viral diarrhea but no benefit against bacterial diarrhea, (C) 2000 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:477 / 481
页数:5
相关论文
共 37 条
  • [1] Prophylactic Lactobacillus GG reduces antibiotic-associated diarrhea in children with respiratory infections:: A randomized study
    Arvola, T
    Laiho, K
    Torkkeli, S
    Mykkänen, H
    Salminen, S
    Maunula, L
    Isolauri, E
    [J]. PEDIATRICS, 1999, 104 (05) : art. no. - e64
  • [2] Antibiotic efficacy in small intestinal bacterial overgrowth-related chronic diarrhea:: A crossover, randomized trial
    Attar, A
    Flourié, B
    Rambaud, JC
    Franchisseur, C
    Ruszniewski, P
    Bouhnik, Y
    [J]. GASTROENTEROLOGY, 1999, 117 (04) : 794 - 797
  • [3] Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model
    Caplan, MS
    Miller-Catchpole, R
    Kaup, S
    Russell, T
    Lickerman, M
    Amer, M
    Xiao, Y
    Thomson, R
    [J]. GASTROENTEROLOGY, 1999, 117 (03) : 577 - 583
  • [4] Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa
    Castagliuolo, I
    Riegler, MF
    Valenick, L
    LaMont, JT
    Pothoulakis, C
    [J]. INFECTION AND IMMUNITY, 1999, 67 (01) : 302 - 307
  • [5] THE CONTROL AND CONSEQUENCES OF BACTERIAL FERMENTATION IN THE HUMAN COLON
    CUMMINGS, JH
    MACFARLANE, GT
    [J]. JOURNAL OF APPLIED BACTERIOLOGY, 1991, 70 (06): : 443 - 459
  • [6] Dai D, 1999, Adv Pediatr, V46, P353
  • [7] Perspectives on bifidobacteria as biotherapeutic agents in gastrointestinal health
    Duffy, LC
    Leavens, A
    Griffiths, E
    Dryja, D
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1999, 44 (08) : 1499 - 1505
  • [8] Immune thrombocytopenic purpura: Why treat?
    Nugent, DJ
    [J]. JOURNAL OF PEDIATRICS, 1999, 134 (01) : 3 - 4
  • [9] Pediatric "PSC-IBD": Inflammatory bowel disease associated with primary sclerosing cholangitis in children.
    Faubion, WA
    Loftus, EV
    Sandborn, WJ
    Freese, DK
    Perrault, J
    [J]. GASTROENTEROLOGY, 2000, 118 (04) : A312 - A312
  • [10] DIETARY MODULATION OF THE HUMAN COLONIC MICROBIOTA - INTRODUCING THE CONCEPT OF PREBIOTICS
    GIBSON, GR
    ROBERFROID, MB
    [J]. JOURNAL OF NUTRITION, 1995, 125 (06) : 1401 - 1412